Vivekanand Jha's Publications
About Vivekanand Jha's Publications
Executive Director, The George Institute for Global Health, India- PHD
-
Trends in the Global Burden of Glomerulonephritis
Clinical Journal of the American Society of Nephrology Date published: -
Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu
Kidney International Date published: -
Our shared responsibility: the urgent necessity of global environmentally sustainable kidney care
Kidney International Date published: -
Infectious Complications and Vaccination in Chronic Kidney Disease
Management of Chronic Kidney Disease Date published: -
Renal revolution: Anticipating the next 25 years of India's kidney care
Indian Journal of Nephrology Date published: -
Indian TrANslational GlomerulonephrItis BioLogy nEtwork (I-TANGIBLE): Design and Methods
Indian Journal of Nephrology Date published: -
Effect of Vitamin D Supplementation on Serum Hepcidin Levels in Non-Diabetic Chronic Kidney Disease Patients
Indian Journal of Nephrology Date published: -
Diabetes and CKD
Management of Kidney Diseases Date published: -
Investigating Kidney Disease
Management of Kidney Diseases Date published: -
The Approach to the Patient with Kidney Disease
Management of Kidney Diseases Date published: -
Management of Kidney Diseases
Management of Kidney Diseases Date published: -
Acute Kidney Injury in the Tropics
pan class="rg-author">Burdmann EA; Jha V; Srisawat N, 2023, 'Acute Kidney Injury in the Tropics', in Comprehensive Clinical Nephrology Date published: -
Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease-findings from the ICKD study
Frontiers in Medicine Date published: -
ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial
Trials Date published: -
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19
NEJM Evidence Date published: -
Heterogeneity of treatment effect of higher dose dexamethasone by geographic region in patients with COVID-19 and severe hypoxemia - Apost hocevaluation of the COVID STEROID 2 trial
Unknown Date published: